-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Neuropathy (Sensory Neuropathy)
Overview How likely is it that the drugs in Peripheral Neuropathy (Sensory Neuropathy) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Neuropathy (Sensory Neuropathy) Overview Peripheral neuropathy refers to a...
-
Product Insights
NewLikelihood of Approval Analysis for Actinic (Solar) Keratosis
Overview How likely is it that the drugs in Actinic (Solar) Keratosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actinic (Solar) Keratosis Overview An actinic keratosis, also known as a...
-
Product Insights
NewLikelihood of Approval Analysis for Alopecia
Overview How likely is it that the drugs in Alopecia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alopecia Overview Alopecia is the partial or complete loss of hair, especially on...
-
Product Insights
NewLikelihood of Approval Analysis for Burns
Overview How likely is it that the drugs in Burns will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Burns Overview Burns result from tissue damage caused by heat, chemicals, electricity, or...
-
Product Insights
NewLikelihood of Approval Analysis for Mixed Pain (Nociceptive Pain/Neuropathic Pain)
Overview How likely is it that the drugs in Mixed Pain (Nociceptive Pain/Neuropathic Pain) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mixed Pain (Nociceptive Pain/Neuropathic Pain) Overview Mixed pain involves...
-
Product Insights
NewLikelihood of Approval Analysis for Neuropathic Pain (Neuralgia)
Overview How likely is it that the drugs in Neuropathic Pain (Neuralgia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuropathic Pain (Neuralgia) Overview Neuropathic pain, also known as neuralgia, is...
-
Product Insights
NewLikelihood of Approval Analysis for Neuropathy
Overview How likely is it that the drugs in Neuropathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuropathy Overview Neuropathy, also known as peripheral neuropathy, refers to a condition involving...
-
Product Insights
NewLikelihood of Approval Analysis for Nociceptive Pain
Overview How likely is it that the drugs in Nociceptive Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nociceptive Pain Overview Nociceptive pain is a type of pain caused by...
-
Product Insights
NewLikelihood of Approval Analysis for Ocular Pain (Eye Pain)
Overview How likely is it that the drugs in Ocular Pain (Eye Pain) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Pain (Eye Pain) Overview Ocular pain, commonly known as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-6302 in Burns
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXS-6302 in Burns report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PXS-6302 in Burns Drug Details: PXS-6302 is under development for the treatment of...